| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of SYNLOGIC INC by Synlogic, Inc. (OTCPK:SYBX) through any online brokerage.
There are no as such competitors for SYNLOGIC INC by Synlogic, Inc..
SYNLOGIC INC by Synlogic, Inc. has a consensus price target of $15.50.
The stock price for SYNLOGIC INC by Synlogic, Inc. (OTCPK: SYBX) is $1.2 last updated August 11, 2026 at 9:26 AM EDT.
There are no upcoming dividends for SYNLOGIC INC by Synlogic, Inc..
SYNLOGIC INC by Synlogic, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for SYNLOGIC INC by Synlogic, Inc..
SYNLOGIC INC by Synlogic, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
